Latest Posts › Investors

Share:

Healthcare Trends & Transactions Q1 2025

The healthcare mergers and acquisitions (M&A) market began 2025 with a slower start than expected given the easing headwinds and building momentum at the end of last year, with the number of deals reported in Q1 lower than...more

State Legislatures Target Private Equity Investments and Corporate Structures in Health Care with New Bills

Many state legislatures have recently convened for 2025 legislative sessions, and members have already proposed a significant number of bills that, if passed, would materially impact transactions and/or corporate structures...more

Healthcare Private Equity Outlook & Trends - January 2025

As some packed the skis and headed to their favorite slopes this winter season, it is hard not to see the analogies to the healthcare private equity (PE) transaction market as we ring in the New Year. Much like the Northern...more

Health Care Investors Conference: 2024 Recap

Bass, Berry & Sims, Deloitte and Harris Williams proudly co-hosted the 14th annual Health Care Investors Conference (HCIC) on October 9 as an associated event of the Nashville Healthcare Sessions conference....more

Pushing a Balloon Into or Against the Jet Stream? Key Takeaways from the J.P. Morgan Healthcare Conference

The 42nd annual J.P. Morgan Healthcare Conference started with clear skies and overall optimism from investors. But with Jamie Dimon’s prediction of a recession in 2024 on Tuesday morning, the climate shifted to an on-again,...more

2024 Healthcare Private Equity Outlook & Trends

W ith various headwinds resulting in down volume in 2023, buyers and sellers alike find themselves asking whether 2024 will see a rebound in deal activity. As we begin 2024, we have highlighted the issues and trends that...more

Health Care Investors Conference: 2023 Recap

Funding Environment Toughest in 40 Years - The consensus of the four members of a panel on funding and financing healthcare is that the environment is tougher than they experienced in the wake of the 2008 financial crisis....more

Healthcare Trends & Transactions Q2 2023

The healthcare M&A market appears to be steadying. Although deal activity through the year appears slightly below the high-water marks for the corresponding period of 2022, deal activity is generally up from the first quarter...more

Top 10 Physician Practice Management Transactional Structure and Operational Challenges

Physician practice management (PPM) platforms have been a staple for over a decade in their current form and are considered a mainstay of private equity’s investment in healthcare. PPMs have a number of unique transaction...more

Sunny Days Ahead? Key Takeaways from Bass, Berry & Sims Connect During the Annual the J.P. Morgan Healthcare Conference

Even the threat of an unprecedented atmospheric river storm could not stop the tried and true from attending the 41st annual J.P. Morgan Healthcare Conference. With a break of sunshine on Monday, we found ourselves asking,...more

2023 Healthcare Private Equity Outlooks & Trends

As we kick off 2023, we are optimistic that the healthcare private equity (PE) market will be resilient despite various headwinds. As you think ahead, please consider the issues and trends summarized below that may be helpful...more

Health Care Investors Conference: 2022 Recap

Bass, Berry & Sims and Deloitte welcomed nearly 75 healthcare investors and executives to the 2022 Health Care Investors Conference on November 9 at the Nashville headquarters of Bass, Berry & Sims...more

Healthcare Transactions Q3 2022

Although healthcare M&A activity in Q3 declined slightly from the previous quarter, analysts believe the activity level declined much less than expected given the numerous headwinds—inflation, rising interest rates, labor...more

Health Care Investors Conference: 2021 Recap

Bass, Berry & Sims and Deloitte presented the 2021 Health Care Investors Conference virtually on November 16... Here are some of the most significant takeaways for healthcare investors from the stimulating discussions and...more

Looking through the Scope: 5 Key Diligence Considerations When Buying a GI Practice

Private equity investors’ interest in gastroenterology (GI) practices continues to remain strong, despite some headwinds that GI practices have experienced as a result of the COVID-19 pandemic and further investment in this...more

Healthcare Transactions: Year in Review - January 2021

2020 was a tumultuous year for the healthcare industry, which continues to confront the effects of the COVID-19 pandemic. Despite these unprecedented and unpredictable times, healthcare merger and acquisition (M&A) activity...more

Key Takeaways from the Nashville Kayo Women in Healthcare and Finance Pop Up Discussion

Investors’ interest in healthcare continues to grow and healthcare-related deal flow in private equity appears to be at an all-time high. On November 5, Bass, Berry, & Sims member Tatjana Paterno moderated a Kayo Women in...more

Believing in Conceiving: Private Equity’s Rebirth in the Fertility Sector

Following the launch of several platforms in recent years, it seems that private equity’s interest in the fertility space is trending up again. Investment in this sector brings some unique issues that potential investors...more

Healthcare Transactions: Year in Review - January 2019

2018 marked a year of continued robust healthcare merger and acquisition activity, with deal volume surpassing that of 2017. The dollar volume of healthcare deals also exceeded 2017, highlighted by CVS Health Corp. (NYSE:...more

20 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide